心血管威廉亚洲博彩公司

订阅

MedSci主页 / 所有栏目 / 心血管威廉亚洲博彩公司

2018 CCS/CAIC威廉亚洲博彩公司 ：抗血小板治疗的应用（更新版）

2017-12-19 加拿大心血管学会 Canadian Journal of Cardiology.December 19, 2017.

抗血小板治疗

抗血小板治疗已经成为预防动脉粥样硬化性疾病尤其是冠心病的重要治疗手段，本文主要更新了2011和2013年加拿大心血管学会(CCS)抗血小板治疗威廉亚洲博彩公司 。推荐意见更新点主要包括：接受PCI治疗的急性冠脉综合征患者双抗治疗的持续时间；接受双抗治疗患者接受非心脏手术以及择期和半紧急冠脉搭桥术的管理；不同口服抗血小板药物的切换；PCI患者的抗血小板和抗凝治疗的管理。

中文标题：

2018 CCS/CAIC威廉亚洲博彩公司 ：抗血小板治疗的应用（更新版）

英文标题：

2018 Canadian Cardiovascular Society (CCS)/Canadian Association of Interventional Cardiology (CAIC) Focused Update of the Guidelines for the use of Antiplatelet Therapy

发布机构：

加拿大心血管学会

发布日期：

2017-12-19

简要介绍：

抗血小板治疗已经成为预防动脉粥样硬化性疾病尤其是冠心病的重要治疗手段，本文主要更新了2011和2013年加拿大心血管学会(CCS)抗血小板治疗威廉亚洲博彩公司 。推荐意见更新点主要包括：接受PCI治疗的急性冠脉综合征患者双抗治疗的持续时间；接受双抗治疗患者接受非心脏手术以及择期和半紧急冠脉搭桥术的管理；不同口服抗血小板药物的切换；PCI患者的抗血小板和抗凝治疗的管理。

 

拓展威廉亚洲博彩公司 ：与抗血小板相关威廉亚洲博彩公司 ：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 CCS/CAIC威廉亚洲博彩公司 ：抗血小板治疗的应用（更新版）)] GetToolGuiderByIdResponse(projectId=1, id=098ce1c0015a03f5, title=2018 CCS/CAIC威廉亚洲博彩公司 ：抗血小板治疗的应用（更新版）, enTitle=2018 Canadian Cardiovascular Society (CCS)/Canadian Association of Interventional Cardiology (CAIC) Focused Update of the Guidelines for the use of Antiplatelet Therapy, guiderFrom=Canadian Journal of Cardiology.December 19, 2017., authorId=null, author=, summary=抗血小板治疗已经成为预防动脉粥样硬化性疾病尤其是冠心病的重要治疗手段，本文主要更新了2011和2013年加拿大心血管学会(CCS)抗血小板治疗威廉亚洲博彩公司 。推荐意见更新点主要包括：接受PCI治疗的急性冠脉综合征患者双抗治疗的持续时间；接受双抗治疗患者接受非心脏手术以及择期和半紧急冠脉搭桥术的管理；不同口服抗血小板药物的切换；PCI患者的抗血小板和抗凝治疗的管理。 , cover=, journalId=null, articlesId=null, associationId=263, associationName=加拿大心血管学会, associationIntro=加拿大心血管学会(CCS)通过传播研究结果和最佳治疗，促进心血管健康。《加拿大心脏病学期刊》（The Canadian Journal of Cardiology,CJC）是加拿大心血管学会(Canadian Cardiovascular Society,CCS)的官方期刊。本刊面向国际，发布心脏病学与心血管病科学新知识，是加拿大心血管学研究成果与加拿大心血管学会指导方针的主要发布场所。本刊发表与心血管医学相关的临床与基础研究的原创报告、社论、评审文章、案例报告，以及关于保健结果、政策研究、道德伦理、医学历史与医学政策问题的论文。, copyright=0, guiderPublishedTime=Tue Dec 19 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>抗血小板治疗已经成为预防动脉粥样硬化性疾病尤其是冠心病的重要治疗手段，本文主要更新了2011和2013年加拿大心血管学会(CCS)抗血小板治疗威廉亚洲博彩公司 。推荐意见更新点主要包括：接受PCI治疗的急性冠脉综合征患者双抗治疗的持续时间；接受双抗治疗患者接受非心脏手术以及择期和半紧急冠脉搭桥术的管理；不同口服抗血小板药物的切换；PCI患者的抗血小板和抗凝治疗的管理。 </P> <P> </P>拓展威廉亚洲博彩公司 ：<strong>与<font color=red>抗血小板</font>相关威廉亚洲博彩公司 ：</strong><br><ul><li><a href="//www.nyrain.com/guideline/show_article.do?id=12c2e1c00153e8c3" title="2017 ASRA/ESRA/AAPM/INS/NANS/WIP威廉亚洲博彩公司 :服用抗血小板和抗凝药物患者进行脊柱和疼痛介入治疗(第2版)" target=_blank>2017 ASRA/ESRA/AAPM/INS/NANS/WIP威廉亚洲博彩公司 :服用抗血小板和抗凝药物患者进行脊柱和疼痛介入治疗(第2版)</a></li> <li><a href="//www.nyrain.com/guideline/show_article.do?id=7cb011c0013e37c8" title="2016 BCSH威廉亚洲博彩公司 ：抗凝和抗血小板治疗围术期管理" target=_blank>2016 BCSH威廉亚洲博彩公司 ：抗凝和抗血小板治疗围术期管理</a></li> <li><a href="//www.nyrain.com/guideline/show_article.do?id=f2d511c00133211f" title="缺血性脑卒中患者围手术期抗血小板药物应用中国专家共识2016" target=_blank>缺血性脑卒中患者围手术期抗血小板药物应用中国专家共识2016</a></li> <li><a href="//www.nyrain.com/guideline/show_article.do?id=c01ca1c0012e19c1" title="2016 冠状动脉旁路移植术围术期抗血小板治疗专家共识" target=_blank>2016 冠状动脉旁路移植术围术期抗血小板治疗专家共识</a></li> <li><a href="//www.nyrain.com/guideline/show_article.do?id=7a4b01c0012e1283" title="2016 稳定性冠心病口服抗血小板药物治疗中国专家共识" target=_blank>2016 稳定性冠心病口服抗血小板药物治疗中国专家共识</a></li> 更多信息请点击：<a href="//www.nyrain.com/guideline/list.do?q=%E6%8A%97%E8%A1%80%E5%B0%8F%E6%9D%BF" target=_blank>有关抗血小板更多威廉亚洲博彩公司 </a></ul>, tagList=[TagDto(tagId=2733, tagName=抗血小板治疗)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=威廉亚洲博彩公司 , guiderLanguage=0, guiderRegion=4, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=11114, appHits=818, showAppHits=11, pcHits=7888, showPcHits=3859, likes=204, shares=25, comments=5, approvalStatus=1, publishedTime=Sat Jan 06 20:59:07 CST 2018, publishedTimeString=2017-12-19, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Jan 06 20:59:07 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 15:42:59 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 CCS/CAIC威廉亚洲博彩公司 ：抗血小板治疗的应用（更新版）)])
2018 CCS/CAIC威廉亚洲博彩公司 ：抗血小板治疗的应用（更新版）
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2211588, encodeId=85652211588d5, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=53802246941, createdName=云行者, createdTime=Tue Jun 25 15:18:46 CST 2024, time=2024-06-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=908148, encodeId=7db5908148b5, content=学习了，实用，谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf645444609, createdName=紫依, createdTime=Tue Dec 15 11:16:19 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276182, encodeId=65aa2e618241, content=谢谢!学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad4c106013, createdName=Drhzm308, createdTime=Sun Jan 07 00:12:17 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276162, encodeId=90162e616271, content=抗血小板治疗已经成为预防动脉粥样硬化性疾病尤其是冠心病的重要治疗手段.本文主要更新了2011和2013年加拿大心血管学会(CCS)抗血小板治疗威廉亚洲博彩公司 .推荐意见更新点主要包括:接受PCI治疗的急性冠脉综合征患者双抗治疗的持续时间,接受双抗治疗患者接受非心脏手术以及择期和半紧急冠脉搭桥术的管理,不同口服抗血小板药物的切换,PCI患者的抗血小板和抗凝治疗的管理., beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sat Jan 06 23:09:10 CST 2018, time=2018-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276141, encodeId=ebc72e61418a, content=学习.谢谢分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sat Jan 06 22:06:24 CST 2018, time=2018-01-06, status=1, ipAttribution=)]
    2024-06-25 云行者 来自福建省

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2211588, encodeId=85652211588d5, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=53802246941, createdName=云行者, createdTime=Tue Jun 25 15:18:46 CST 2024, time=2024-06-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=908148, encodeId=7db5908148b5, content=学习了，实用，谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf645444609, createdName=紫依, createdTime=Tue Dec 15 11:16:19 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276182, encodeId=65aa2e618241, content=谢谢!学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad4c106013, createdName=Drhzm308, createdTime=Sun Jan 07 00:12:17 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276162, encodeId=90162e616271, content=抗血小板治疗已经成为预防动脉粥样硬化性疾病尤其是冠心病的重要治疗手段.本文主要更新了2011和2013年加拿大心血管学会(CCS)抗血小板治疗威廉亚洲博彩公司 .推荐意见更新点主要包括:接受PCI治疗的急性冠脉综合征患者双抗治疗的持续时间,接受双抗治疗患者接受非心脏手术以及择期和半紧急冠脉搭桥术的管理,不同口服抗血小板药物的切换,PCI患者的抗血小板和抗凝治疗的管理., beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sat Jan 06 23:09:10 CST 2018, time=2018-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276141, encodeId=ebc72e61418a, content=学习.谢谢分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sat Jan 06 22:06:24 CST 2018, time=2018-01-06, status=1, ipAttribution=)]
    2020-12-15 紫依

    学习了，实用，谢谢分享。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2211588, encodeId=85652211588d5, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=53802246941, createdName=云行者, createdTime=Tue Jun 25 15:18:46 CST 2024, time=2024-06-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=908148, encodeId=7db5908148b5, content=学习了，实用，谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf645444609, createdName=紫依, createdTime=Tue Dec 15 11:16:19 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276182, encodeId=65aa2e618241, content=谢谢!学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad4c106013, createdName=Drhzm308, createdTime=Sun Jan 07 00:12:17 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276162, encodeId=90162e616271, content=抗血小板治疗已经成为预防动脉粥样硬化性疾病尤其是冠心病的重要治疗手段.本文主要更新了2011和2013年加拿大心血管学会(CCS)抗血小板治疗威廉亚洲博彩公司 .推荐意见更新点主要包括:接受PCI治疗的急性冠脉综合征患者双抗治疗的持续时间,接受双抗治疗患者接受非心脏手术以及择期和半紧急冠脉搭桥术的管理,不同口服抗血小板药物的切换,PCI患者的抗血小板和抗凝治疗的管理., beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sat Jan 06 23:09:10 CST 2018, time=2018-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276141, encodeId=ebc72e61418a, content=学习.谢谢分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sat Jan 06 22:06:24 CST 2018, time=2018-01-06, status=1, ipAttribution=)]
    2018-01-07 Drhzm308

    谢谢!学习了!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2211588, encodeId=85652211588d5, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=53802246941, createdName=云行者, createdTime=Tue Jun 25 15:18:46 CST 2024, time=2024-06-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=908148, encodeId=7db5908148b5, content=学习了，实用，谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf645444609, createdName=紫依, createdTime=Tue Dec 15 11:16:19 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276182, encodeId=65aa2e618241, content=谢谢!学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad4c106013, createdName=Drhzm308, createdTime=Sun Jan 07 00:12:17 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276162, encodeId=90162e616271, content=抗血小板治疗已经成为预防动脉粥样硬化性疾病尤其是冠心病的重要治疗手段.本文主要更新了2011和2013年加拿大心血管学会(CCS)抗血小板治疗威廉亚洲博彩公司 .推荐意见更新点主要包括:接受PCI治疗的急性冠脉综合征患者双抗治疗的持续时间,接受双抗治疗患者接受非心脏手术以及择期和半紧急冠脉搭桥术的管理,不同口服抗血小板药物的切换,PCI患者的抗血小板和抗凝治疗的管理., beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sat Jan 06 23:09:10 CST 2018, time=2018-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276141, encodeId=ebc72e61418a, content=学习.谢谢分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sat Jan 06 22:06:24 CST 2018, time=2018-01-06, status=1, ipAttribution=)]
    2018-01-06 有备才能无患

    抗血小板治疗已经成为预防动脉粥样硬化性疾病尤其是冠心病的重要治疗手段.本文主要更新了2011和2013年加拿大心血管学会(CCS)抗血小板治疗威廉亚洲博彩公司 .推荐意见更新点主要包括:接受PCI治疗的急性冠脉综合征患者双抗治疗的持续时间,接受双抗治疗患者接受非心脏手术以及择期和半紧急冠脉搭桥术的管理,不同口服抗血小板药物的切换,PCI患者的抗血小板和抗凝治疗的管理.

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2211588, encodeId=85652211588d5, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=53802246941, createdName=云行者, createdTime=Tue Jun 25 15:18:46 CST 2024, time=2024-06-25, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=908148, encodeId=7db5908148b5, content=学习了，实用，谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf645444609, createdName=紫依, createdTime=Tue Dec 15 11:16:19 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276182, encodeId=65aa2e618241, content=谢谢!学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad4c106013, createdName=Drhzm308, createdTime=Sun Jan 07 00:12:17 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276162, encodeId=90162e616271, content=抗血小板治疗已经成为预防动脉粥样硬化性疾病尤其是冠心病的重要治疗手段.本文主要更新了2011和2013年加拿大心血管学会(CCS)抗血小板治疗威廉亚洲博彩公司 .推荐意见更新点主要包括:接受PCI治疗的急性冠脉综合征患者双抗治疗的持续时间,接受双抗治疗患者接受非心脏手术以及择期和半紧急冠脉搭桥术的管理,不同口服抗血小板药物的切换,PCI患者的抗血小板和抗凝治疗的管理., beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sat Jan 06 23:09:10 CST 2018, time=2018-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=276141, encodeId=ebc72e61418a, content=学习.谢谢分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sat Jan 06 22:06:24 CST 2018, time=2018-01-06, status=1, ipAttribution=)]
    2018-01-06 天地飞扬

    学习.谢谢分享!

    0

相关威廉亚洲博彩公司

2016 BCSH威廉亚洲博彩公司 ：抗凝和抗血小板治疗围术期管理

英国血液学标准委员会(BCSH,British Committee for Standards in Haematology) · 2016-10-07

2016 冠状动脉旁路移植术围术期抗血小板治疗专家共识

暂未更新 · 2016-01-30